U.S. Markets open in 6 hrs 25 mins

Sequenom upgraded to Overweight from Equal Weight at Stephens

Stephens upgraded Sequenom based on the positive ACOG's Committee on Genetics recommendation that cell-free fetal DNA testing be used in high-risk women. Price target raised to $8 from $4.